Trial Profile

Proof of Concept Study of Eurartesim in Patients With Imported Uncomplicated Plasmodium Vivax Malaria

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 12 Apr 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dihydroartemisinin/piperaquine (Primary)
Indications Vivax malaria
Focus Proof of concept; Therapeutic Use
Sponsors Alfasigma; sigma-tau SpA

Most Recent Events

13 Jun 2017 Status changed from recruiting to discontinued due to low recruitment.
03 May 2017 This trial has been discontinued in Germany (end date: 31 Dec 2016).
05 Apr 2017 This trial was discontinued in Italy, according to European Clinical Trials Database.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com